Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat in Relapsed/Refractory Acute Leukemia
NCT00723203Phase 2Terminated
- Sponsor
- City of Hope
- Start
- Apr 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by City of Hope. Started Apr 2008; status: terminated.
02
Drugs
panobinostat
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00723203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723203.